Surgihoney® is a bioengineered, medical grade honey providing superior efficacy in preventing biofilm formation compared to other honeys[1].
It has broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria, including multi-drug resistant strains, such as MRSA, Ecoli and Pseudomonas aeruginosa[2].
Surgihoney® is supported by a growing body of evidence from both laboratory and clinical research.
- 60% surgical site infection reduction compared to normal wound dressings[7]
- Results of a 114 multicentre patient study in a variety of non-healing, deteriorating or static wounds with a mean treatment period of 25.7 days[3] with Surgihoney®:
- 100% of wounds improved
- 21% wound closure during the study period
- Reduction in patient pain
- Excellent debridement
- Effective at preventing biofilms – ranging from 79% (with PS 1586) to 94.1% (with PS PA01). All of these reductions are statistically significant (p<0.05)[1]
Surgihoney® Clinical Studies
| Author(s) | Title | Publication | ||
|---|---|---|---|---|
| 1 | Halstead, F.D., Webber, M.A., et al. | In vitro activity of an engineered honey, medical-grade honeys and antimicrobial wound dressings against biofilm-producing clinical bacterial isolates | JWC, Vol 25, No 2, February 2016 | View |
| 2 | Dryden, M., Lockyer, G., Kordo, S. and Cooke, J. | Engineered honey: in vitro antimicrobial activity of a novel topical wound care treatment | Journal of Global Antimicrobial Resistance 2014, Vol 2, 3, 168-172 | View |
| 3 | Dryden, M., et al. | A multi-centre clinical evaluation of Reactive Oxygen™ topical wound gel in 114 wounds | JWC, Vol 25, No 3, March 2016 | View |
| 4 | Cooke, J., Dryden, M., Patton, T., Brennan, J. and Barrett, J. | The antimicrobial activity of prototype modified honeys that generate Reactive Oxygen™ species (ROS) hydrogen peroxide | BMC research notes. 2015; 8(1):20. doi:10.1186/s13104-014-0960-4. | View |
| 5 | Dunnill, C., Patton, T., Brennan, J., et al. | Reactive Oxygen™ species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process | International Wound Journal, 2015, 21. doi: 10.1111/iwj.12557 | View |
| 6 | Dryden, M., Milward, G., Saeed, K. | Infection prevention in wounds with Surgihoney | Journal of Hospital Infection, 2014, Vol 88, 2, 121-122 | View |
| 7 | Dryden, M., Goddard, C., Madadi, A., Heard, M., Saeed, K., Cooke, J. | Bioengineered Surgihoney as an antimicrobial wound dressing to prevent Caesarean wound infection: a clinical and cost-effectiveness study | British Journal of Midwifery 2014; 22:23–7 | |
| 8. | Williams, R., Khan, W., Metah, A., MorganJones, R. | Honey as a Novel Antimicrobial Coating in Salvage Revision Total Knee Arthroplasty | View | |
| 9. | Reactive Oxygen: a new solution to antimicrobial resistance | British Journal of Nursing 2016, Vol 25, No 12. | View | |
| 10. | Williams, R., Khan, W., Metah, A., MorganJones, R. | Honey as a Novel Antimicrobial Coating in Salvage Revision Total Knee Arthroplasty | View |
